Number of the records: 1  

HPMA copolymer conjugate with pirarubicin: In vitro and ex vivo stability and drug release study

  1. 1.
    SYSNO ASEP0482175
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleHPMA copolymer conjugate with pirarubicin: In vitro and ex vivo stability and drug release study
    Author(s) Islam, W. (JP)
    Fang, J. (JP)
    Etrych, Tomáš (UMCH-V) RID, ORCID
    Chytil, Petr (UMCH-V) RID, ORCID
    Ulbrich, Karel (UMCH-V) RID
    Sakoguchi, A. (JP)
    Kusakabe, K. (JP)
    Maeda, H. (JP)
    Source TitleInternational Journal of Pharmaceutics. - : Elsevier - ISSN 0378-5173
    Roč. 536, č. 1 (2018), s. 108-115
    Number of pages8 s.
    Languageeng - English
    CountryGB - United Kingdom
    KeywordsEPR effect ; HPMA copolymer ; tumor-targeting
    Subject RIVFR - Pharmacology ; Medidal Chemistry
    OECD categoryPharmacology and pharmacy
    R&D ProjectsGA15-02986S GA ČR - Czech Science Foundation (CSF)
    LQ1604 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    ED1.1.00/02.0109 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Institutional supportUMCH-V - RVO:61389013
    UT WOS000424259100011
    EID SCOPUS85035026360
    DOI10.1016/j.ijpharm.2017.11.011
    AnnotationWe have developed a tumor environment-responsive polymeric anticancer prodrug containing pirarubicin (THP) conjugated to N-(2-hydroxypropyl) methacrylamide copolymer (PHPMA), [P-THP], through a spacer containing pH-sensitive hydrazone bond, that showed remarkable therapeutic effect against various tumor models and in a human pilot study. Toward clinical development, here we report THP release profile from its HPMA copolymer conjugate, the conjugate stability, protein and cell-binding and solubility of P-THP. Size exclusion chromatography of P-THP (molecular weight 38 kDa) showed similar hydrodynamic volume as bovine serum albumin (BSA) in aqueous solution, with no apparent interactions with BSA, nor aggregation by itself. pH-responsive release of free THP was reconfirmed at pHs 6.5 and lower. The drug release was significantly affected by a type of used buffer. Phosphate buffer seems to facilitate faster hydrazone bond cleavage at pH 7.4 whereas higher stability was achieved in L-arginine solution which yielded only little cleavage and THP release, approx. 15% within 2 weeks at the same pH at 25 °C. Furthermore, ex vivo study using sera of different animal species showed very high stability of P-THP. Incubation with blood showed high stability of P-THP during circulation, without binding to blood cells. These findings revealed that L-arginine solution provides appropriate media for formulation of P-THP infusion solution as tumor-targeted polymeric anticancer drug based on EPR effect.
    WorkplaceInstitute of Macromolecular Chemistry
    ContactEva Čechová, cechova@imc.cas.cz ; Tel.: 296 809 358
    Year of Publishing2019
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.